Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Silence Therapeutics Plc American Depository Share (SLN)

https://www.silence-therapeutics.com

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risk of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/08/2020

Market Cap

743,818,464

Shares Outstanding

107,810,000

Weighted SO

38,669,929

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.2970

Last Div

0.0000

Range

6.15-27.72

Chg

-0.8000

Avg Vol

204112

Mkt Cap

743818464

Exch

NASDAQ

Country

GB

Phone

44 20 3457 6900

DCF Diff

17.2633

DCF

5.5767

Div Yield

0.0000

P/S

21.7664

EV Multiple

-11.6471

P/FV

4.3785

Div Yield %

0.0000

P/E

-15.5273

PEG

-2.1738

Payout

0.0000

Current Ratio

12.8198

Quick Ratio

12.8198

Cash Ratio

7.9752

DSO

260.2700

DIO

0.0000

Op Cycle

260.2700

DPO

478.6489

CCC

-218.3789

Gross Margin

0.6972

Op Margin

-1.5758

Pretax Margin

-1.5527

Net Margin

-1.3231

Eff Tax Rate

0.1479

ROA

-0.1797

ROE

-0.8069

ROCE

-0.2309

NI/EBT

0.8521

EBT/EBIT

0.9854

EBIT/Rev

-1.5758

Debt Ratio

0.0014

D/E

0.0022

LT Debt/Cap

0.0008

Total Debt/Cap

0.0022

Int Coverage

-48.8966

CF/Debt

-141.4765

Equity Multi

1.5688

Rec Turnover

1.4024

Pay Turnover

0.7626

Inv Turnover

0.0000

FA Turnover

14.7443

Asset Turnover

0.1359

OCF/Share

-0.8915

FCF/Share

-0.8919

Cash/Share

3.4748

OCF/Sales

-1.4840

FCF/OCF

1.0005

CF Coverage

-141.4765

ST Coverage

-212.9837

CapEx Coverage

-2177.1667

Div&CapEx Cov

-2177.1667

P/BV

4.3785

P/B

4.3785

P/S

21.7664

P/E

-15.5273

P/FCF

-14.6603

P/OCF

-13.8433

P/CF

-13.8433

PEG

-2.1738

P/S

21.7664

EV Multiple

-11.6471

P/FV

4.3785

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 16, 06:00 Annual General Meeting of 17 June 2025 Investing.com Jul 20, 02:42 Soleno Therapeutics enters agreement to sell $150 million in stock By Investing.com - Investing.com Canada GlobeNewswire Inc. Jan 08, 06:45 ASLAN Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement Benzinga Dec 28, 14:09 Forget The Magnificent 7: Did Anyone Back These 1,000% Gainers In 2023? MarketWatch Dec 28, 09:40 The best-performing stock of the year rose nearly 10-fold, while the 2nd-best averted disaster to surge 1,000% in a wild 2023 MarketWatch Dec 28, 09:40 The best-performing stock of the year rose nearly 10-fold, while the 2nd-best averted disaster to surge 1,000% in a wild 2023 MarketWatch Dec 28, 04:52 The best-performing stock of the year rose nearly 10-fold, while the 2nd-best averted disaster to surge 1,000% in a wild 2023 MarketWatch Dec 27, 14:46 The best-performing stock of the year rose nearly 10-fold, while the 2nd-best averted disaster to surge 1,000% in a wild 2023 MarketWatch Dec 27, 14:46 The best-performing stock of the year rose nearly 10-fold, while the 2nd-best averted disaster to surge 1,000% in a wild 2023 The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday The Motley Fool Dec 21, 18:59 Why Soleno Therapeutics Stock Ticked Higher on Thursday Benzinga Nov 21, 13:00 4 Analysts Have This to Say About Soleno Therapeutics GlobeNewswire Inc. Nov 10, 16:05 Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation